Antigen processing and autoimmunity - Evaluation of mRNA abundance and function of HLA-linked genes

Annals of the New York Academy of Sciences

Volumn 842, Issue , 1998, Pages 138-155

  Fu, Yineng ^a   Yan, Gang ^a   Shi, Lijia ^a   Faustman, Denise ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; MESSENGER RNA; PEPTIDASE; PROTEASOME;

ADULT; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; SJOEGREN SYNDROME; TWINS;

EID: 0031979338     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09642.x     Document Type: Article

References (57)

1. MARRACK, P. & J. KAPPLER. 1987. The T cell receptor. Science 238: 1073-1079.
2. TSOMIDES, T.J. & H.N. EISEN. 1991. Antigenic structures recognized by cytotoxic T-lymphocytes. J. Biol. Chem. 266: 3357-3360.
3. FAUSTMAN, D. et al. 1991. Linkage of faulty major histocompatibility complex class I to autoimmune diabetes. Science 254: 1756-1761.
4. Fu, Y. et al. 1993. Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity. J. Clin. Invest. 91: 2301-2307.
5. Li, F. et al. 1995. Reduced expression of peptide-Ioaded HLA class I molecules on multiple sclerosis lymphocytes. Ann. Neurol. 38: 147-154.
6. + T cell repertoire in β2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility complex class I. J. Exp. Med. 179: 661-672.
7. + T cells in TAP-1 mutant mice. Proc. Natl. Acad. Sci. USA 91: 6525-6528.
8. 2-microglobulin, MHC class I-deficient mice. Proc. Natl. Acad. Sci. USA 90: 2837-2841.
9. 2-M -/- knockout mice contain low levels of CD8+ cytotoxic T lymphocytes that mediate specific tumor rejection. J. Immunol. 151: 6281-6290.
10. 2-microglobulin-negative, MHC class I-deficient mice in response to immunization with tumor cells. J. Immunol. 152: 2087-2097.
11. DE LA SALLE, H. et al. 1994. Homozygous human Tap peptide transporter mutation in HLA class I deficiency. Science 265: 237-241.
12. ASHTON-RICKARDT, P.G. et al. 1994. Evidence for a differential avidity model of T cell selection in the thymus. Cell 76: 651-663.
13. HOGQUIST, K.A. et al. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
14. DEVERSON, E.V. et al. 1990. MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters. Nature 348: 738-741.
15. TROWSDALE, J. et al. 1990. Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters. Nature 348: 741-744.
16. SPIES, T. et al. 1990. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 348: 744-747.
17. MONACO, J.J. et al. 1990. Transport protein genes in the murine MHC: possible implications for antigen processing. Science 250: 1723-1726.
18. LIVINGSTONE, A.M. et al. 1989. A transacting major histocompatibility complex-linked gene whose alleles determine gain and loss changes in the antigenic structure of a classical class I molecule. J. Exp. Med. 170: 777-795.
19. NEEFJES, J.J. & H.L. PLOEGH. 1992. Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistant αβ heterodimers in endosomes. EMBO J. 11: 411-416.
20. SHEPHERD, J.C. et al. 1993. TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell 74: 577-584.
21. MONACO, J.J. & H.O. McDEVITT. 1982. Identification of a fourth class of proteins linked to the murine major histocompatibility complex. Proc. Natl. Acad. Sci. USA 79: 3001-3005.
22. PARHAM, P. 1990. Antigen processing. Transporters of delight. Nature 348: 674-675.
23. GOLDBERO, A.L. & K.L. ROCK. 1992. Proteolysis, proteasomes and antigen presentation. Nature 357: 375-379.
24. GLYNNE, R. et al. 1991. A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature 353: 357-360.
25. KELLY, A. et al. 1991. Second proteasome-related gene in the human MHC class II region. Nature 353: 667-668.
26. ORTIZ-NAVARETTE, V.et al. 1991. Subunit of the '20S' proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex. Nature 353: 662-664.
27. Li, F. et al. 1994. Abnormal class I assembly and peptide presentation in the diabetic NOD mouse. Proc. Natl. Acad. Sci. USA 91: 11128-11132.
28. PEARCE, R.B. et al. 1993. Polymorphism in the mouse Tap-1 gene. Association with abnormal CD8+ T cell development in the nonobese nondiabetic mouse. J. Immunol. 151: 5338-5347.
29. WICKER, L.S. et al. 1992. Expression of intra-MHC transporter (Ham) genes and class I antigens in diabetes-susceptible NOD mice. Science 256: 1826-1831.
30. + cytotoxic T-cell responses in autoimmune diabetes-prone NOD mice. Diabetes 45: 902-908.
31. 2-microglobulin-negative mice. Diabetes 44: 1114-1120.
32. TAKEI, I. et al. 1992. Suppression of development of diabetes in NOD mice by lactate dehydrogenase virus infection. J. Autoimmunity 5: 665-674.
33. SATOH, J. et al. 1988. Treatment with streptococcal preparation (OK0432) suppresses antiislet autoimmunity and prevents diabetes in BB rats. Diabetes 37: 1188-1194.
34. AKI, M. et al. 1994. Interferon-γ induces different subunit organizations and functional diversity of proteasomes. J. Biochem. 115: 257-269.
35. VAN KAER, L. et al. 1994. Altered peptidase and viral-specific T cell response in LMP-2 mutant mice. Immunity 1: 533-541.
36. WILBERZ, S. et al. 1991. Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia 34: 2-5.
37. HERMITTE, L. et al. 1990. Paradoxical lessening of autoimmune processes in nonobese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus. Eur. J. Immunol. 20: 1297-1303.
38. KAWAMURA, T. et al. 1993. Prevention of autoimmune type I diabetes by CD4+ suppressor T cells in superantigen-treated nonobese diabetic mice. J. Immunol. 151: 4362-4370.
39. KINO, K. et al. 1990. An immunomodulating protein Ling Zhi-8 (LZ-8) prevents insulitis in nonobese diabetic mice. Diabetologia 33: 713-718.
40. ELIAS, D. et al. 1990. Induction and therapy of autoimmune diabetes in the nonobese diabetic (NOD/lt) mouse by a 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA 87: 1576-1580.
41. SADELAIN, M.W.J. et al. 1990. Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39: 583-589.
42. MCINERNEY, M.F. et al 1991. Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice. Diabetes 40: 715-725.
43. HUANG, R. et al. 1995. Elimination of self-peptide major histocompatibility complex class I reactivity in NOD and β2-microglobulin-negative mice. Diabetes 44: 1114-1120.
44. MUIR, A. & N.K. MACLAREN. 1991. Autoimmune diseases of the adrenal glands, parathyroid glands, gonads, and hypothalamicpituitary axis. Endocrinol. Metab. Clin. North Am. 20: 619-644.
45. AHOHEN, P. et al 1988. The expression of autoimmune polyglandular disease Type I appears associated with several HLA-A antigens but now with HLA-DR. J. Clin. Endocrinol. Metab. 66: 1152-1157.
46. MUKUSICK, V.A. 1992. Mendelian Inheritance in Man. Johns Hopkins University Press. Baltimore.
47. MACLAREN, N.K. & W.J. RILEY. 1986. Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigens-DR3 and/or DR4, except when associated with type I autoimmune polyglandular syndrome. J. Clin. Endocrin. Metab. 62: 455-459.
48. RABINOWE, S.L. & G.S. EISENBARTH. 1986. Polyglandular autoimmunity. Adv. Intern. Med. 31: 293-307.
49. AALTONEN, J. et al. 1994. An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nat. Genet. 8: 83-87.
50. AHONEN, P. 1985. Autoimmune polyendocrinopathy-candidosis-ectodermal-dystrophy (APECED): Autosomal recessive inheritance. Clin. Genet. 27: 535-542.
51. AALTONEN, J. et al 1993. Autoimmune polyglandular disease type I. Exclusion map using amplifiable multiallelic markers in a microtiter well format. Eur. J. Hum. Genet. 1: 164-171.
52. AHOHEN, P. et al 1990. Clinical variation of autoimmune polyendocrinopathy-candidiasisectodermal dystrophy (APECED) in a series of 68 patients. N. Engl. J. Med. 322: 1829-1836.
53. WAGNER, R. et al. 1994. Lack of immunohistological changes in the islets of non-diabetic, autoimmune, polyendocrine patients with beta-selective GAD-specific islet cell antibodies. Diabetes 43: 851-856.
54. BOTTAZZO, G.F. et al 1974. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2: 1279-1283.
55. 54a. CECIL: Textbook of Medicine, 19th Ed. 1988. J.B. Wyngaarden & L.H. Smith, Eds. W.B. Saunders Company. Philadelphia, PA.
56. GACZYNSKA, M. et al. 1994. Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP-2 and LMP-7. Proc. Natl. Acad. Sci. USA 91: 9213-9217.
57. FEHLING, H.J. et al 1994. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265: 1234-1237.